Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.

Grunberger G, Bhargava A, Ly T, Zisser H, Ilag LL, Malone J, Fan L, Zhang S, Johnson J

Open source

DOI
10.1111/dom.13947
Published
2020 Mar
Container
Diabetes, obesity & metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.13947,
  title = {Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.},
  author = {Grunberger G and Bhargava A and Ly T and Zisser H and Ilag LL and Malone J and Fan L and Zhang S and Johnson J},
  year = {2020},
  journal = {Diabetes, obesity \& metabolism},
  doi = {10.1111/dom.13947},
  url = {https://doi.org/10.1111/dom.13947}
}

RIS

TY  - JOUR
TI  - Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.
AU  - Grunberger G
AU  - Bhargava A
AU  - Ly T
AU  - Zisser H
AU  - Ilag LL
AU  - Malone J
AU  - Fan L
AU  - Zhang S
AU  - Johnson J
PY  - 2020
JO  - Diabetes, obesity & metabolism
DO  - 10.1111/dom.13947
UR  - https://doi.org/10.1111/dom.13947
ER  - 

APA

G, G., A, B., T, L., H, Z., LL, I., J, M., L, F., S, Z., & J, J. (2020). Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.13947

Source records